ALPS ‘SBIO’ ETF: Trial Progress Meets Investing Success
January 25, 2021 at 09:22 AM EST
Clinical trials are of the utmost importance to biotechnology investors, but not all exchange traded funds adequately address the phenomenon. The ALPS Medical Breakthroughs ETF (SBIO) takes a different approach. SBIO focuses on small- and mid-cap companies that have one or more drugs in either...